Learning curve for robot-assisted laparoscopic radical prostatectomy in a large prospective multicentre study.


Journal

Scandinavian journal of urology
ISSN: 2168-1813
Titre abrégé: Scand J Urol
Pays: Sweden
ID NLM: 101587186

Informations de publication

Date de publication:
Jun 2022
Historique:
pubmed: 13 5 2022
medline: 1 7 2022
entrez: 12 5 2022
Statut: ppublish

Résumé

Differences in outcome after radical prostatectomy for prostate cancer can partly be explained by intersurgeon differences, where degree of experience is one important aspect. This study aims to define the learning curve of robot-assisted laparoscopic prostatectomy (RALP) regarding oncological and functional outcomes. Out of 4003 enrolled patients in the LAPPRO trial, 3583 met the inclusion criteria, of whom 885 were operated on by an open technique. In total, 2672 patients with clinically localized prostate cancer from seven Swedish centres were operated on by RALP and followed for 8 years (LAPPRO trial). Oncological outcomes were pathology-reported surgical margins and biochemical recurrence at 8 years. Functional outcomes included patient-reported urinary incontinence and erectile dysfunction at 3, 12 and 24 months. Experience was surgeon-reported experience before and during the study. The relationship between surgeon experience and functional outcomes and surgical margin status was analysed by mixed-effects logistic regression. Biochemical recurrence was analysed by Cox regression, with robust standard errors. The learning curve for positive surgical margins was relatively flat, with rates of 21% for surgeons who had performed 0-74 cases and 24% for surgeons with > 300 cases. Biochemical recurrence at 4 years was 11% (0-74 cases) and 13% (> 300 cases). Incontinence was stable over the learning curve, but erectile function improved at 2 years, from 38% (0-74 cases) to 53% (> 300 cases). Analysis of the learning curve for surgeons performing RALP showed that erectile function improved with increasing number of procedures, which was not the case for oncological outcomes.

Identifiants

pubmed: 35546102
doi: 10.1080/21681805.2022.2070274
pmc: PMC9380413
mid: NIHMS1822702
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

182-190

Subventions

Organisme : NCI NIH HHS
ID : K22 CA234400
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States

Références

Eur Urol. 2004 Aug;46(2):195-9
pubmed: 15245813
J Urol. 2010 Mar;183(3):977-82
pubmed: 20083278
Eur Urol Open Sci. 2021 Jun 19;30:25-33
pubmed: 34337544
BMC Med Res Methodol. 2009 Jul 28;9:57
pubmed: 19638200
BMC Res Notes. 2010 Sep 02;3:234
pubmed: 20813026
Eur Urol Focus. 2019 May;5(3):389-398
pubmed: 29366855
BMC Urol. 2014 Mar 06;14:25
pubmed: 24602348
J Gastrointest Surg. 2020 Nov;24(11):2628-2636
pubmed: 31745899
J Urol. 1998 Jun;159(6):1988-92
pubmed: 9598504
J Urol. 2010 Apr;183(4):1360-5
pubmed: 20171687
Eur Urol. 2021 Nov;80(5):650-660
pubmed: 34538508
Eur J Cancer. 2012 Jan;48(1):46-53
pubmed: 21676610
Eur Urol Oncol. 2018 Oct;1(5):353-360
pubmed: 31158073
Eur Urol. 2015 Aug;68(2):216-25
pubmed: 25770484
Eur Urol. 2014 Mar;65(3):521-31
pubmed: 24287319
J Urol. 2019 Jul;202(1):108-113
pubmed: 30747873
BJU Int. 2021 Mar;127(3):361-368
pubmed: 32916021
Eur Urol Open Sci. 2020 Aug 19;20:54-61
pubmed: 34337458
J Natl Cancer Inst. 2007 Aug 1;99(15):1171-7
pubmed: 17652279
Scand J Urol Nephrol. 2011 Mar;45(2):102-12
pubmed: 21114378
Eur Urol. 2008 May;53(5):960-6
pubmed: 18207316
J Urol. 2008 Jun;179(6):2212-6; discussion 2216-7
pubmed: 18423716
Eur Urol. 2015 Mar;67(3):559-68
pubmed: 25457018

Auteurs

David Bock (D)

Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Scandinavian Surgical Outcomes Research Group, Gothenburg, Sweden.

Martin Nyberg (M)

Department of Translational Medicine, Division of Urological Cancers, Faculty of Medicine, Lund University, Lund, Sweden.
Department of Urology, Skåne University Hospital, Malmö, Sweden.

Anna Lantz (A)

Department of Molecular Medicine and Surgery, Section of Urology, Karolinska Institute, Stockholm, Sweden.
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

Sigrid V Carlsson (SV)

Departments of Surgery (Urology Service) and Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Daniel D Sjoberg (DD)

Departments of Surgery (Urology Service) and Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Stefan Carlsson (S)

Department of Molecular Medicine and Surgery, Section of Urology, Karolinska Institute, Stockholm, Sweden.

Johan Stranne (J)

Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Department of Urology Gothenburg, Region Västra Götaland, Sahlgrenska University Hospital, Goteborg, Sweden.

Gunnar Steineck (G)

Department of Oncology, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.

Peter Wiklund (P)

Department of Urology, Icahn School of Medicine at Mount Sinai Health System, New York, NY, USA.

Eva Haglind (E)

Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Scandinavian Surgical Outcomes Research Group, Gothenburg, Sweden.
Department of Surgery, Region Västra Götaland, Sahlgrenska University Hospital/Östra, Gothenburg, Sweden.

Anders Bjartell (A)

Department of Translational Medicine, Division of Urological Cancers, Faculty of Medicine, Lund University, Lund, Sweden.
Department of Urology, Skåne University Hospital, Malmö, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH